The CCK-system underpins novelty-seeking behavior in the rat: Gene expression and pharmacological analyses

Neuropeptides

Volumn 42, Issue 3, 2008, Pages 245-253

  Ballaz, Santiago J ^a   Akil, Huda ^b   Watson, Stanley J ^b  

^a UNIVERSITY OF LISBON   (Portugal)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

5 HT7 receptor; CCK 2R; Cholecystokinin; LY225.910; M2 receptor; Novelty seeking behavior

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; MESSENGER RNA; SEROTONIN 7 RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN REGION; FOREBRAIN; GENE EXPRESSION; GENETICS; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; MODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; OPEN FIELD TEST; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STIMULUS; THALAMUS DORSOMEDIAL NUCLEUS; VENTRAL TEGMENTUM;

ANIMALS; AUTORADIOGRAPHY; CHOLECYSTOKININ; EXPLORATORY BEHAVIOR; GENE EXPRESSION; IMAGE PROCESSING, COMPUTER-ASSISTED; IN SITU HYBRIDIZATION; MALE; MOTOR ACTIVITY; PHENOTYPE; QUINAZOLINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M2; RECEPTORS, CHOLECYSTOKININ; RECEPTORS, SEROTONIN; RNA, MESSENGER;

ANIMALIA; RATTUS;

EID: 44649161781     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2008.03.001     Document Type: Article

References (48)

1. Abelson J.L. Cholecystokinin in psychiatric research: a time for cautious excitement. J. Psychiat. Res. 29 (1995) 389-396
2. Ballaz S., Akil H., and Watson S.J. The CCK-system mediates adaptation to novelty-induced stress in the rat: a pharmacological evidence. Neurosci. Lett. 428 (2007) 27-32
3. Ballaz S., Akil H., and Watson S.J. Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior. Neuroscience 147 (2007) 428-438
4. Becker, C., Zeau, B., Rivat, C., Blugeot, A., Hamon, M., Benoliel, J.J., 2007. Repeat social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokynin. Mol. Psychiat. doi:10.1016/sj.mp.4002097.
5. Beracochea D.J., Jaffard R., and Jarrad L.E. Effects of anterior or dorsomedial thalamic ibotenic lesions on learning and memory in rats. Behav. Neural. Biol. 51 (1989) 364-376
6. Biró E., Penke B., and Teledgy G. Role of different neurotransmitter systems in the cholecystokinin octapeptide-induced anxiogenic response in rats. Neuropeptides 31 (1997) 281-285
7. Bradwejn J., and de Montigny C. Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones. Nature 312 (1984) 363-364
8. Bradwejn J., Koszycki D., and Shriqui C. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch. Gen. Psychiat. 48 (1991) 603-610
9. Breukel A.I., Lopes da Silva F.H., and Ghijsen W.E. Cholecystokinin (CCK-8) modulates vesicular release of excitatory amino acids in rat hippocampal nerve endings. Neurosci. Lett. 234 (1997) 67-70
10. Cain M.E., Saucier D.A., and Bardo M.T. Novelty seeking and drug use: contribution of an animal model. Exp. Clin. Psychopharmacol. 13 (2005) 367-375
11. Chen Q., Nakajima A., Meacham C., and Tang Y.P. Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 3881-3886
12. Crawley J.N. Cholecystokinin modulates dopamine-mediated behaviors. Differential actions in medial posterior versus anterior nucleus accumbens. Ann. N.Y. Acad. Sci. 713 (1994) 138-142
13. Crawley J.N., and Corwin R.L. Biological actions of cholecystokinin. Peptides 15 (1994) 731-755
14. Dauge V., and Lena I. CCK in anxiety and cognitive processes. Neurosci. Biobehav. Rev. 22 (1998) 815-825
15. Dauge V., Sebret A., Beslot F., Matsui T., and Roques B.P. Behavioral profile of CCK2 receptor-deficient mice. Neuropsychopharmacology 25 (2001) 690-698
16. Dellu F., Piazza P.V., Mayo W., Le Moal M., and Simon H. Novelty-seeking in rats - biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology 34 (1996) 136-145
17. Dias R., and Honey R.C. Involvement of the rat medial prefrontal cortex in novelty detection. Behav. Neurosci. 116 (2002) 498-503
18. Farook J.M., Zhu Y.Z., Wang H., Moochhala S., Lee L., and Wong P.T. Strain differences in freezing behavior of PVG hooded and Sprague-Dawley rats: differential cortical expression of cholecystokinin2 receptors. Neuroreport 12 (2001) 2717-2720
19. Floresco S.B., and Grace A.A. Gating of hippocampal-evoked activity in prefrontal cortical neurons by inputs from the mediodorsal thalamus and ventral tegmental area. J. Neurosci. 23 (2003) 3930-3943
20. Griebel G. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?. Pharmacol. Ther. 82 (1999) 1-61
21. Harrigan T., Predery O., and Persinger M. Radial Maze learning deficits and mediodorsal thalamic damage in context of multifocal seizure-induced brain lesions. Behav. Neurosci. 105 (1991) 482-486
22. Harro J., and Vasar E. Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat. Eur. J. Pharmacol. 193 (1991) 379-381
23. Hedlund P.B., Huitron-Resendiz S., Henriksen S.J., and Sutcliffe J.G. 5-HT7 receptor inhibition and inactivation induce antidepressant like behavior and sleep pattern. Biol. Psychiat. 58 (2005) 831-837
24. Higgins G.A., Sills T.L., Tomkins D.M., Sellers E.M., and Vaccarino F.J. Evidence for the contribution of CCKB receptor mechanisms to individual differences in amphetamine-induced locomotion. Pharmacol. Biochem. Behav. 48 (1994) 1019-1024
25. Hokfelt T., Blacker D., Broberger C., Herrera-Marschitz M., Snyder G., Fisone G., Cortes R., Morino P., You Z.B., and Ogren S.O. Some aspects on the anatomy and function of central cholecystokinin systems. Pharmacol. Toxicol. 91 (2002) 382-386
26. Horvitz J.C. Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience 96 (2000) 651-656
27. Kabbaj M., Devine D.P., Savage V.R., and Akil H. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J. Neurosci. 20 (2000) 6983-6988
28. Kabbaj M. Neurobiological basis of individual differences in emotional and stress responsiveness. Arch. Neurol. 61 (2004) 1009-1012
29. Krettek J.E., and Price J.L. The cortical projections of the mediodorsal nucleus and adjacent thalamic nuclei in the rat. J. Comp. Neurol. 171 (1977) 157-192
30. Ladurelle N., Roques B.P., and Dauge V. The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens. J. Neurosci. 15 (1995) 3118-3127
31. Le Moal M., and Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev. 71 (1991) 155-234
32. Lucas L.R., Angulo J.A., Le Moal M., McEwen B.S., and Piazza P.V. Neurochemical characterization of individual vulnerability to addictive drugs in rats. Eur. J. Neurosci. 10 (1998) 3153-3163
33. Matto V., Harro J., and Allikmets L. The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat. Neuropharmacology 36 (1997) 389-396
34. Meneses A. Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task. Behav. Brain Res. 155 (2004) 275-282
35. Noble F., and Roques B.P. Phenotypes of mice with invalidation of cholecystokinin (CCK(1) or CCK(2)) receptors. Neuropeptides 36 (2002) 157-170
36. Piazza P.V., Deminiere J.M., Le Moal M., and Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 245 (1989) 1511-1513
37. Piazza P.V., Rouge-Pont F., Deminiere J.M., Kharoubi M., Le Moal M., and Simon H. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res. 567 (1991) 169-174
38. Piazza P.V., and Le Moal M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 19 (1998) 67-74
39. Rosario L.A., and Abercrombie E.D. Individual differences in behavioral reactivity: correlation with stress-induced norepinephrine efflux in the hippocampus of Sprague-Dawley rats. Brain Res. Bull. 48 (1999) 595-602
40. Rotzinger S., Bush D.E., and Vaccarino F.J. Cholecystokinin modulation of mesolimbic dopamine function: regulation of motivated behavior. Pharmacol. Toxicol. 91 (2002) 404-413
41. Sarter M., Bodewitz G., and Steckler T. 2-[3H]deoxyglucose uptake patterns in rats exploring a six-arm radial tunnel maze: differences between experienced and nonexperienced rats. Behav. Neurosci. 103 (1989) 1217-1225
42. Sebret A., Lena I., Crete D., Matsui T., Roques B.P., and Dauge V. Rat hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-B receptor stimulation. J. Neurosci. 19 (1999) 7230-7237
43. Seeger T., Fedorova I., Zheng F., Miyakawa T., Koustova E., Gomeza J., Basile A.S., Alzheimer C., and Wess J. M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity. J. Neurosci. 24 (2004) 10117-10127
44. Suman-Chauhan N., Meecham K.G., Webdale L., Hunter J.C., Pritchard M.C., Woodruff G.N., and Hill D.R. The influence of guanyl nucleotide on agonist and antagonist affinity at guinea-pig CCK-B/gastrin receptors: binding studies using [3H]PD140376. Regul. Pept. 65 (1996) 37-43
45. van Megen H.J., Westenberg H.G., den Boer J.A., and Kahn R.S. Cholecystokinin in anxiety. Eur. Neuropsychopharmacol. 6 (1996) 263-280
46. Vilaro M.T., Wiederhold K.H., Palacios J.M., and Mengod G. Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography. Neuroscience 47 (1992) 367-693
47. Wang H., Zhu Y.Z., Farook J.M., Moochhala S., Teo A.L., Lee L.K., and Wong P.T. Genetic variations in CCK2 receptor in PVG hooded and Sprague-Dawley rats and its mRNA expression on cat exposure. Behav. Neurosci. 117 (2003) 385-390
48. Zuckerman M., and Neeb M. Sensation seeking and psychopathology. Psychiat. Res. 1 (1979) 255-264